Cargando…
Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Gene...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Biotechnology and Bioengineering
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790479/ https://www.ncbi.nlm.nih.gov/pubmed/33437151 http://dx.doi.org/10.1007/s12257-020-0049-y |
_version_ | 1783633433616973824 |
---|---|
author | Kim, Hyunho Kim, Eunyoung Lee, Ingoo Bae, Bongsung Park, Minsu Nam, Hojung |
author_facet | Kim, Hyunho Kim, Eunyoung Lee, Ingoo Bae, Bongsung Park, Minsu Nam, Hojung |
author_sort | Kim, Hyunho |
collection | PubMed |
description | As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Generally, AI is applied to fields with sufficient data such as computer vision and natural language processing, but there are many efforts to revolutionize the existing drug discovery process by applying AI. This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning. The main data sources in each field are also summarized in this review. In addition, an in-depth analysis of the remaining challenges and limitations will be provided, and proposals for promising future directions in each of the aforementioned areas. |
format | Online Article Text |
id | pubmed-7790479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society for Biotechnology and Bioengineering |
record_format | MEDLINE/PubMed |
spelling | pubmed-77904792021-01-08 Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches Kim, Hyunho Kim, Eunyoung Lee, Ingoo Bae, Bongsung Park, Minsu Nam, Hojung Biotechnol Bioprocess Eng Review Paper As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Generally, AI is applied to fields with sufficient data such as computer vision and natural language processing, but there are many efforts to revolutionize the existing drug discovery process by applying AI. This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning. The main data sources in each field are also summarized in this review. In addition, an in-depth analysis of the remaining challenges and limitations will be provided, and proposals for promising future directions in each of the aforementioned areas. The Korean Society for Biotechnology and Bioengineering 2021-01-07 2020 /pmc/articles/PMC7790479/ /pubmed/33437151 http://dx.doi.org/10.1007/s12257-020-0049-y Text en © The Korean Society for Biotechnology and Bioengineering and Springer 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Paper Kim, Hyunho Kim, Eunyoung Lee, Ingoo Bae, Bongsung Park, Minsu Nam, Hojung Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title | Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title_full | Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title_fullStr | Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title_full_unstemmed | Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title_short | Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches |
title_sort | artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790479/ https://www.ncbi.nlm.nih.gov/pubmed/33437151 http://dx.doi.org/10.1007/s12257-020-0049-y |
work_keys_str_mv | AT kimhyunho artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches AT kimeunyoung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches AT leeingoo artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches AT baebongsung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches AT parkminsu artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches AT namhojung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches |